Robert Essner

Robert A. Essner is Chairman at Elucida Oncology, Inc. since 2021.
He is Director at The Children's Health Fund and Elorac, Inc. He is Lead Independent Director at Organon & Co. starting 2025.
He is Trustee at Lincoln Center for the Performing Arts, Inc. and Mote Marine Laboratory, Inc. Formerly, Mr. Essner was Chief Executive Officer at Fort Dodge Animal Health, Inc. He was Chairman at Wyeth LLC in 2008 and Chairman at Wyeth Pharmaceuticals, Inc. from 2007 to 2008.
He served as Chairman at Pharmaceutical Research & Manufacturers of America.
He was Lead Director at Massachusetts Mutual Life Insurance Co. from 2012 to 2014.
He was Director at The Nature's Bounty Co., Pharmaceutical Product Development LLC, Nissay Wealth Life Insurance KK, Alphabet Holding Co., Inc., MassMutual Financial Group (Connecticut), and Trustee at Trustees of the University of Pennsylvania.
He was Independent Director at Amicus Therapeutics, Inc. from 2012 to 2022.
He was Senior Advisor at The Carlyle Group LP (Corporate Private Equity).
He was President at Ayerst Laboratories, Inc. from 1993 to 1997 and President-Consumer Healthcare Group at Sandoz Pharmaceuticals Corp.
Education includes graduate studies at The University of Chicago and undergraduate studies at Miami University.